Dominik Höchli
Director/Board Member bei MOLECULAR PARTNERS AG
Profil
Dominik Höchli is currently the Chief Executive Officer at Catapult Therapeutics BV and an Independent Director at Molecular Partners AG.
He previously worked as the Vice President & Head-Global Medical Affairs at AbbVie AG.
He holds a doctorate degree from the University of Bern.
Aktive Positionen von Dominik Höchli
| Unternehmen | Position | Beginn |
|---|---|---|
| MOLECULAR PARTNERS AG | Director/Board Member | 21.04.2021 |
Catapult Therapeutics BV
 Catapult Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Catapult Therapeutics BV operates as a biopharmaceutical company which develops cancer treatments. It is developing CAP-100, a humanized anti-CCR7 antibody. The company was founded in 2015 and is headquartered in Lelystad, the Netherlands. | Chief Executive Officer | 01.01.2021 |
Ehemalige bekannte Positionen von Dominik Höchli
| Unternehmen | Position | Ende |
|---|---|---|
| AbbVie AG | Corporate Officer/Principal | - |
Ausbildung von Dominik Höchli
| University of Bern | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| MOLECULAR PARTNERS AG | Health Technology |
| Private Unternehmen | 2 |
|---|---|
| AbbVie AG | |
Catapult Therapeutics BV
Catapult Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Catapult Therapeutics BV operates as a biopharmaceutical company which develops cancer treatments. It is developing CAP-100, a humanized anti-CCR7 antibody. The company was founded in 2015 and is headquartered in Lelystad, the Netherlands. | Commercial Services |
